SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Anta Sports Expands Global Footprint With Strategic Puma Stake 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
LONDON, Jan. 04, 2018 -- The pharmaceuticals industry is going through one of its most exciting periods yet. Generic pharmaceuticals have taken off, leading to much more innovation in the market and a wave of consolidation across the US.
Keeping on top of all these changes is Robert Wessman, CEO and founder of pharmaceuticals organisation Alvogen. His knack for spotting industry developments has seen the company soar to great heights and become a pharmaceutical leader.
Wessman recently spoke to World Finance magazine, in a three-part video series, to share his knowledge – and predictions – for the pharmaceutical market.
Though only created in 2009, Alvogen has grown substantially over the years. Wessman discusses its inception in the video series; astonishingly, the vision for Alvogen was initially sketched out on a napkin. Wessman had met investors in a New York restaurant and it was the easiest way to communicate his pharmaceutical vision. They were sold.
Today, Alvogen’s ability to thrive in one of the world’s most competitive sectors is underpinned by its fast responses to industry movements and strong team.
Later on in the video series, Wessman gives his top tips for leadership, explaining what traits are needed in order to make a business work. He also explains why it’s so important to know what you’re looking for in recruitment – so as to build the perfect team.
For some of the best insights in the generics pharmaceutical industry, go to World Finance online – where the three-part video series is available:
https://www.worldfinance.com/videos/alvogen-founder-generic-drug-price-wars-will-drive-consolidation
https://www.worldfinance.com/videos/i-took-my-napkin-and-off-we-went-robert-wessmans-billion-dollar-vision
https://www.worldfinance.com/videos/robert-wessman-a-leader-must-be-able-to-act-when-most-others-dont
World News Media is a leading publisher of quality financial and business magazines, which enjoys a global distribution network that includes subscriber lists of prominent decision-makers around the world.
CONTACT INFORMATION
World News Media
Elizabeth Matsangou
Editorial Department
+44 (0)20 7553 4162
[email protected]
